
10,000+ employees
🧬 Biotechnology
💊 Pharmaceuticals
💰 $3.5M Post-IPO Debt - Gilead Sciences on 2024-11
Biotechnology • Pharmaceuticals
Gilead Sciences is a global biopharmaceutical company focused on researching, developing, and commercializing medicines primarily in virology, oncology, and inflammation. The company advances transformative therapies, runs extensive clinical programs and research collaborations, and supports access, global health, and community funding initiatives. Gilead also emphasizes corporate responsibility, sustainability, and inclusion while maintaining a broad pipeline of therapies and patient access programs.
🔥 4 hours ago
Congress Manager supporting Tier 1 congress planning and operational execution for Gilead and Kite. Collaborating with cross-functional teams to uphold process excellence for congress-related activities.
🇺🇸 United States – Remote
💵 $115.3k - $149.2k / year
💰 $3.5M Post-IPO Debt - Gilead Sciences on 2024-11
⏰ Full Time
🟡 Mid-level
🟠 Senior
👔 Manager
🦅 H1B Visa Sponsor